| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.07B | 10.84B | 10.05B | 37.45B | 37.21B | 26.66B |
| Gross Profit | 2.74B | 2.77B | 2.91B | 25.12B | 26.13B | 18.83B |
| EBITDA | 369.01M | 326.79M | 612.41M | -177.33M | 2.50B | 1.51B |
| Net Income | 23.46B | 17.23B | -3.78B | 6.88B | 2.82B | 47.38M |
Balance Sheet | ||||||
| Total Assets | 53.87B | 53.13B | 46.84B | 41.77B | 82.09B | 49.79B |
| Cash, Cash Equivalents and Short-Term Investments | 9.59B | 9.97B | 15.95B | 14.04B | 32.78B | 32.53B |
| Total Debt | 2.73B | 2.59B | 1.42B | 474.82M | 3.80B | 6.46B |
| Total Liabilities | 6.62B | 5.52B | 9.58B | 6.75B | 55.05B | 28.96B |
| Stockholders Equity | 47.25B | 47.61B | 37.26B | 35.01B | 27.04B | 16.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.92B | 2.39B | -14.43B | 2.95B | 5.51B |
| Operating Cash Flow | 0.00 | -1.67B | 2.51B | -13.52B | 3.63B | 6.11B |
| Investing Cash Flow | 0.00 | 2.95B | -3.56B | -23.53B | 4.28B | -910.83M |
| Financing Cash Flow | 0.00 | -829.42M | -385.21M | 23.97B | -3.30B | 3.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥73.21B | 23.18 | ― | 2.73% | 6.41% | 16.71% | |
66 Neutral | ¥181.63B | 8.81 | 13.53% | 1.34% | 0.48% | -1.86% | |
66 Neutral | ¥92.65B | 12.03 | ― | 1.99% | 3.71% | -3.32% | |
64 Neutral | ¥189.25B | 19.80 | 25.11% | 1.15% | -12.94% | 2390.52% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥6.34T | -69.04 | 4.25% | 1.99% | -6.96% | -7.22% | |
49 Neutral | ¥413.84B | 5.68 | ― | ― | -10.88% | ― |